BioVaxys Technology (TSE:BIOV) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
BioVaxys Technology Corp. has successfully closed the second tranche of its non-brokered private placement, raising $175,000 by issuing 3.5 million units at $0.05 per unit. The funds will be used to boost the company’s working capital, with each unit comprising one common share and a warrant convertible at $0.15 by December 2026.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.
